3 Great Reasons Why Unilever plc Is Set To Take Off

Royston Wild looks at the major share price drivers for Unilever plc (LON: ULVR).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at why I believe Unilever (LSE: ULVR) (NYSE: UL.US) is an excellent stock selection for savvy investors.

Spicy growth prospects in emerging regions

Unilever noted in July’s half-year results release that surging performance in developing regions had experienced some slowdown in recent months, the impact of wider macroeconomic issues applying pressure on its customers’ wallets.

Despite slowing activity here, however, underlying sales growth still rose by a more than respectable 10.3% during January-June, which helped drive group sales 5% higher. And the firm continues to gear up its presence in these territories to undergird future growth, including the bolstering of its stake in India’s Hindustan Unilever to 67% in July.

The household goods giant’s share price has fallen almost 10% since July’s release, which I believe represents a fresh buying opportunity. Despite recent price weakness, the firm is still trading at a premium to its food processor and producer peers, dealing on a prospective price-to-earnings (P/E) rating of 18 versus an average of 13.3 for its sector rivals. But I believe that still-lucrative growth rates in new markets, combined with the strength and thus pricing power of its key brands, justifies this elevated rating.

Strong product pipeline keeps on delivering

Unilever continues to bring on line innovations across its bulging product portfolio, and the introduction of its compressed deodorant products, Dove ‘Repair Expertise’ and ‘Men+Care’ hair range and Magnum5 kisses’ ice creams, have all performed well since rollout earlier this year.

The company’s constant merry-go-round of product relaunches — such as its Lipton Yellow Label tea brand — and introduction of established brands in new markets is also showing strong promise. Recent successful introductions include Pond’s Flawless White BB skin cream, which is undergoing widespread rollout in new geographies after a successful launch in Thailand.

Food sales ready to unlock more value?

Some commentators believe that the purchase of H.J. Heinz Company by Warren Buffett’s Berkshire Hathaway Inc. and private-equity firm 3G Capital in June could herald waves of interest from potential buyers for Unilever’s Food division.

Indeed, this division — which generates sales of around $26bn per year — spun off its Wish-Bone and Western salad dressings brands to Pinnacle Foods last month, for around $580m or more than three times enterprise-value-to-sales (EV/sales). Food is undoubtedly the laggard of the group, with sales rising just 0.2% in January-June versus 5% for the whole group.

So, in my opinion, the premium that Unilever could attract for these underperforming food assets could see more labels hit the chopping block, delivering extra shareholder value and removing some of the flotsam to create a more streamlined group.

Let the Fool electrify your investment portfolio

Regardless of whether you already hold shares in Unilever, and you are looking for other lucrative payout plays to really propel the returns from your stock portfolio, I strongly recommend taking a look at this exclusive, in-depth report about another FTSE 100 high-income opportunity.

The blue chip in question offers a prospective dividend yield comfortably north of 5%, and is currently “The Motley Fool’s Top Income Stock“! Click here to download the report now — it’s absolutely free and comes with no further obligation.

> Royston does not own shares in Unilever. The Motley Fool has recommended shares in Unilever.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »